358 results on '"Eichstaedt, Christina"'
Search Results
2. Hereditäre pulmonal-arterielle Hypertonie
3. Kommentar zu den Leitlinien (2022) der ESC/ERS zur Diagnostik und Behandlung der pulmonalen Hypertonie
4. Genetic background of pulmonary (vascular) diseases – how much is written in the codes?
5. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis
6. Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension
7. Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study
8. Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension
9. Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial
10. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
11. The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review
12. Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
13. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
14. Pulmonale Hypertonie bei Erwachsenen mit angeborenen Herzfehlern im Lichte der 2022-ESC-PAH-Leitlinien
15. Genetically Identifying the “Thrombo-embolic” in CTEPH
16. Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis
17. Genomic analyses inform on migration events during the peopling of Eurasia
18. NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD
19. A recent bottleneck of Y chromosome diversity coincides with a global change in culture
20. Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
21. Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study.
22. Pulmonale arterielle Hypertonie bei Erwachsenen mit angeborenen Herzfehlern – Teil I
23. Neue Aspekte bei der pulmonalen Hypertonie im Kindesalter – kommentierte 2022ERS/ESC-PH-Guidelines
24. Genetische Diagnostik und molekulare Ansätze bei pulmonalarterieller Hypertonie
25. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
26. Adaptations in Andean populations : the genetics of hypoxia protection
27. Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018
28. SMAD5 as a novel gene for familial pulmonary arterial hypertension
29. Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension
30. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up
31. Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension
32. The role of rehabilitation in patients with pulmonary arterial hypertension
33. Gender-related differences in pulmonary arterial hypertension targeted drugs administration
34. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
35. Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
36. Genetic counselling and testing in pulmonary arterial hypertension:a consensus statement on behalf of the International Consortium for Genetic Studies in PAH
37. Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?
38. Genetische Grundlagen, Beratung und Testung bei Patienten mit pulmonalarterieller Hypertonie
39. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
40. Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD
41. Genetics of High-Altitude Pulmonary Edema
42. Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension
43. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
44. Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH
45. The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review
46. Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension
47. Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
48. Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
49. Pulmonalarterielle Hypertonie bei Frauen
50. Additional file 1 of Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.